Introduction and Chairman’s Overview Clotting, Cancer and Controversies: What the Trials and Current Thinking Tell Us Program Chairman: Craig M. Kessler, MD
Cancer, Thrombosis and the Biology of Malignancy: A Science-to-Clinical Strategy Perspective – The Role of LMWH at the Interface of Thrombosis and Cancer John Fanikos, RPh, MBA
VTE Prophylaxis, Monitoring and Management in the Setting of Cancer: Critical Challenges, Identifying Patients at Risk and Landmark Trials Craig M. Kessler
VTE Prophylaxis in the Cancer Patient and Beyond: Guidelines and Implications for Day-to-Day Practice Samuel Z. Goldhaber, MD
Question and Answer Session Faculty Panel